Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

This study has been completed.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: June 18, 2002
Last updated: May 17, 2012
Last verified: May 2012